J35: Multi-material, greyscale 3D printing from the desktop.

A team of professionals at the Institute of Cancer Research, London, has utilized the J5 MediJet™ 3D printer to create a first-of-its-kind model that accurately depicts the protein being targeted within a cancer cell by novel drugs in development.

Jacob Institute medical collaborators pioneer 3D printing solutions with a collective vision to design and establish a vascular care center for the future.